Crucell and Scripps find antibody for universal flu vax

Tools

Researchers at Crucell and the Scripps Research Institute have discovered a new antibody that could lead to a universal flu vaccine. According to animal test results, the antibody, CR6261, neutralized multiple flu strains, including H3N2, which killed 1 million people in Asia during the late 1960s. And researchers have found CR8020 is a complementary antibody, which fights the flu strains not affected by CR6261. Release

Comments